Since July, the European Commission has been investing in speeding up the development of potential Covid-19 vaccines - and securing doses for EU citizens.
While the development of a vaccine can normally take up to 10 years, researchers worldwide are trying to shorten the process from 18 months to just 12 months.
Last week, the commission signed its first contract, on behalf of member states, with British pharmaceutical firm AstraZeneca for the supply of Enjoy access to all articles and 25 years of archives, comment and gift articles. Become a member for as low as €1,75 per week.To read this story, log in or subscribe
Elena is EUobserver's editor-in-chief. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.
Elena is EUobserver's editor-in-chief. She is from Spain and has studied journalism and new media in Spanish and Belgian universities. Previously she worked on European affairs at VoteWatch Europe and the Spanish news agency EFE.